Octapharma France Sas v Agence Nationale De Securite Du Medicament Et Des Produits De Sante and Ministere Des Affaires Sociales et De La Sante: ECJ 7 Nov 2013

ECJ Opinion – Approximation of legislation – Directive 2001/83/EC – Directive 2004/27/EC – Directive 2002/98/EC – Scope of application – Labile blood products – Plasma prepared by a method involving an industrial process – Simultaneous or exclusive application of Directive 2001/83 (as amended by Directive 2004/27) and Directive 2002/98 – Article 168(4) TFEU and Member State discretion to maintain more stringent protective measures for blood and blood derivatives

Judges:

Jaaskine AG

Citations:

C-512/12, [2013] EUECJ C-512/12, [2014] EUECJ C-512/12

Links:

Bailii, Bailii

Statutes:

Directive 2001/83/EC, Directive 2002/98/EC, Directive 2004/27/EC

Jurisdiction:

European

European

Updated: 25 October 2022; Ref: scu.517563